Weight-loss surgery before kidney transplantation improves health and eligibility of patients with obesity and renal failure, Mayo Clinic study finds

Weight-loss surgery before kidney transplantation improves health and eligibility of patients with obesity and renal failure, Mayo Clinic study finds By Share this: ROCHESTER, Minn. — Laparoscopic sleeve gastrectomy promotes relatively rapid weight loss, reduces obesity-related health issues and improves eligibility for kidney transplantation for patients with advanced chronic kidney…

Continue reading

Mayo Clinic Platform_Accelerate graduation shows promise of health tech innovation for improving patient care

ROCHESTER, Minn. — Mayo Clinic Platform_Accelerate celebrated the graduation of its fourth cohort of health tech startups, including nine innovative businesses from around the world. During the graduation event, held March 28 in Eagan, Minnesota, each company presented progress and outcomes from the 20-week accelerator program, providing a glimpse into…

Continue reading

Mayo Clinic scientists pioneer immunotherapy technique for autoimmune diseases

Mesenchymal stromal cell ROCHESTER, Minn. — Mayo Clinic scientists have developed an immunotherapy strategy that potentially lays the groundwork for treating a spectrum of autoimmune diseases. The new technique, detailed in a preclinical study published in Nature Biomedical Engineering, involves combining chimeric antigen receptors (CAR) with mesenchymal stromal cells (MSC),…

Continue reading

Mayo Clinic Platform expands global footprint of its distributed data network  

The first-of-its-kind alliance moves into new regions to transform global healthcare and improve access, diagnostics and treatments for patients everywhere. ROCHESTER, Minn. — Mayo Clinic Platform continues to expand its distributed data network, Mayo Clinic Platform_Connect1, which now includes eight of the world’s leading health systems across three continents: Seoul…

Continue reading

New study finds triple-negative breast cancer tumors with an increase in immune cells have lower risk of recurrence after surgery

ROCHESTER, Minn. — A new multicenter, international study suggests that people who have early-stage triple-negative breast cancer (TNBC) and high levels of immune cells within their tumors may have a lower risk of recurrence and better survival rates even when not treated with chemotherapy. The study was published today in…

Continue reading